Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Uda

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Acta Neuropathologica Communications|April 16, 2025
Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort studyHirokazu Nakatogawa, Junya Fukai, Hiroshi Kawaji, et al.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Acta Neuropathologica Communications|October 1, 2024
Correction: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Acta Neuropathologica Communications|December 6, 2018
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsKohei Fukuoka, Yonehiro Kanemura, Tomoko Shofuda, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Acta Neuropathologica Communications|April 16, 2025
Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort studyHirokazu Nakatogawa, Junya Fukai, Hiroshi Kawaji, et al.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Acta Neuropathologica Communications|October 1, 2024
Correction: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Acta Neuropathologica Communications|December 6, 2018
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsKohei Fukuoka, Yonehiro Kanemura, Tomoko Shofuda, et al.
Pageof 11